HIGHLIGHTS
- who: J. Janssen from the Department of Radiation Oncology, University Medical Center have published the Article: Androgen Deprivation therapy for Oligo-recurrent Prostate cancer in addition to radioTherapy (ADOPT): study protocol for a randomised phase III trial, in the Journal: (JOURNAL) of 10/03/2020
- what: To eliminate potential (micro)metastases that are not (yet) visible and to enhance the therapeutic effect, the authors propose to combine targeted MDRT with a short course of_(neo) adjuvant ADT. This approach has already been proven successful in primary treatment of high risk PCa reducing local recurrence, improving . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.